Evidence that tamoxifen binds to calmodulin in a conformation different to that when binding to estrogen receptors, through structure-activity study on ring-fused analogues

This publication has 18 references indexed in Scilit:

• Investigation of the Mechanism of Tamoxifen-Stimulated Breast Tumor Growth With Nonisomerizable Analogues of Tamoxifen and Metabolites
  JNCI Journal of the National Cancer Institute, 1993
• Properties of a purified estradiol-dependent calf uterus tyrosine kinase
  Biochemistry, 1993
• Antagonistic effect of triphenylethylenic antiestrogens on the association of estrogen receptor to calmodulin
  Biochemical and Biophysical Research Communications, 1992
• Interaction of the dihydropyridine calcium antagonist, CD-349, with calmodulin
  Biochemical Pharmacology, 1990
• Variation of the inhibition of calmodulin dependent cyclic AMP phosphodiesterase amongst analogues of tamoxifen; Correlations with cytotoxicity
  Biochemical Pharmacology, 1990
• Effects of Tamoxifen, Tamoxifen Metabolites, and Nafoxidine on Adenosine 3′,5′-Monophosphate Phosphodiesterase: Correlations with Growth Inhibitory Activities but not Estrogen Receptor Affinities^*
  Endocrinology, 1989
• In VitroInteraction of Estradiol Receptor with Ca²⁺-Calmodulin
  Molecular Endocrinology, 1988
• Synthesis and estrogen receptor binding of 6,7-dihydro-8-phenyl-9-[4-[2-(dimethylamino)ethoxy]phenyl]-5H-benzocycloheptene, a nonisomerizable analog of tamoxifen. X-ray crystallographic studies
  Journal of Medicinal Chemistry, 1986
• Fluorescence investigations of calmodulin hydrophobic sites
  Biochemical and Biophysical Research Communications, 1984
• Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesterase
  Biochemical and Biophysical Research Communications, 1984